Healio

Orthopedic surgeons can take ABOS Subspecialty Examinations earlier

Please provide your email address to receive an email when new articles are posted on . Orthopedic surgeons are now able to take Subspecialty Certification Examinations offered by the American Board ...
Healio

ABOS peer review and case list: Understand modifications, importance

Please provide your email address to receive an email when new articles are posted on . In my last article, I discussed the American Board of Orthopaedic Surgery Maintenance of Certification (MOC) ...
Nasdaq

Citigroup Initiates Coverage of Acumen Pharmaceuticals (ABOS) with Buy Recommendation

As of July 24, 2024, the average one-year price target for Acumen Pharmaceuticals is $13.06/share. The forecasts range from a low of $10.10 to a high of $15.75. The average price target represents an ...
Hosted on MSN

Acumen Pharmaceuticals (ABOS) Price Target Decreased by 20.59% to 6.88

) has been revised to $6.88 / share. This is a decrease of 20.59% from the prior estimate of $8.67 dated November 7, 2025. The price target is an average of many targets provided by analysts. The ...
Nasdaq

Acumen Pharmaceuticals (ABOS) Price Target Increased by 6.67% to 13.06

The average one-year price target for Acumen Pharmaceuticals (NasdaqGS:ABOS) has been revised to 13.06 / share. This is an increase of 6.67% from the prior estimate of 12.24 dated March 28, 2024. The ...